Reacquired License for Quasi-drug Manufacturing and Marketing
October 30, 2025
As of October 30, 2025, our company has
reacquired the license for quasi-drug manufacturing and marketing
from the Tokyo Metropolitan Government.
With this renewed authorization, we will continue to strengthen our quality
and safety management systems and remain committed to delivering products
that customers can use with confidence.
